ESC Premium Access

Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Topic: Diabetes and the Heart
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly

Presentation

About the speakers

Professor Stephan Jacob

Villingen (Germany)
6 presentations
0 follower

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)
26 presentations
0 follower

Professor Francesco Cosentino

Unit of Cardiology, Karolinska Institute & Karolinska University Hospital, Stockholm (Sweden)
22 presentations
0 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)
36 presentations
1 follower

2 more presentations in this session

Introduction - Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Speaker: Professor F. Cosentino (Stockholm, SE)

Thumbnail

Targeting SGLT2 inhibition in cardiology: what is the profile of benefit?

Speaker: Professor N. Marx (Aachen, DE)

Thumbnail

Access the full session

Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure

Speakers: Professor S. Jacob, Professor N. Marx, Professor F. Cosentino, Professor J. Deanfield, Professor F. Cosentino...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk